An Evaluation of the Drone Delivery of Adrenaline Auto-Injectors for Anaphylaxis: Pharmacists’ Perceptions, Acceptance, and Concerns

Anaphylaxis is a life-threatening condition where delays in medical treatment can be fatal. Such situations would benefit from the drone delivery of an adrenaline auto-injector such as EpiPen<sup>®</sup>. This study evaluates the potential risk, reward, and impact of drone transportation...

Full description

Bibliographic Details
Main Authors: September Beck, Tam T. Bui, Andrew Davies, Patrick Courtney, Alex Brown, Jef Geudens, Paul G. Royall
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Drones
Subjects:
Online Access:https://www.mdpi.com/2504-446X/4/4/66
_version_ 1797551472695574528
author September Beck
Tam T. Bui
Andrew Davies
Patrick Courtney
Alex Brown
Jef Geudens
Paul G. Royall
author_facet September Beck
Tam T. Bui
Andrew Davies
Patrick Courtney
Alex Brown
Jef Geudens
Paul G. Royall
author_sort September Beck
collection DOAJ
description Anaphylaxis is a life-threatening condition where delays in medical treatment can be fatal. Such situations would benefit from the drone delivery of an adrenaline auto-injector such as EpiPen<sup>®</sup>. This study evaluates the potential risk, reward, and impact of drone transportation on the stability of adrenaline during episodes of anaphylaxis. Further, this study examines pharmacists’ perceptions on drone delivery—pharmacists approved the use of drones to deliver EpiPen<sup>®</sup> during emergencies but had concerns with drone safety and supply chain security. Laboratory simulated onboard drone conditions reflected typical missions. In these experiments, in vitro model and pharmaceutical equivalent formulations were subjected independently to 30 min vibrations at 5, 8.43, and 13.33 Hz, and temperature storage at 4, 25, 40, and 65 °C for 0, 0.5, 3, and 24 h. The chiral composition (an indicator of chemical purity that relates to molecular structure) and concentration of these adrenaline formulations were determined using ultraviolet (UV) and circular dichroism spectroscopy (CD). Adrenaline intrinsic stability was also explored by edge-of-failure experimentation to signpost the uppermost limits for safe transportation. During drone flight with EpiPen<sup>®</sup>, the temperature and vibration g-force were 10.7 °C and 1.8 g, respectively. No adverse impact on adrenaline was observed during drone flight and laboratory-simulated conditions shown by conformation to the British Pharmacopeia standards (<i>p</i> > 0.05 for CD and UV). This study showed that drone delivery of EpiPen<sup>®</sup> is feasible. There are more than 15,000 community pharmacies and ≈9000 GP surgeries spanning the UK, which are likely to provide achievable ranges and distances for the direct drone delivery of EpiPen<sup>®</sup>. The authors recommend that when designing future missions, in addition to medicine stability testing that models the stresses imposed by drone flight, one must conduct a perceptions survey on the relevant group of medical professionals, because their insights, acceptance, and concerns are extremely valuable for the design and evaluation of the mission.
first_indexed 2024-03-10T15:46:32Z
format Article
id doaj.art-3ee221213d7540cabfd023919745195d
institution Directory Open Access Journal
issn 2504-446X
language English
last_indexed 2024-03-10T15:46:32Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Drones
spelling doaj.art-3ee221213d7540cabfd023919745195d2023-11-20T16:25:08ZengMDPI AGDrones2504-446X2020-10-01446610.3390/drones4040066An Evaluation of the Drone Delivery of Adrenaline Auto-Injectors for Anaphylaxis: Pharmacists’ Perceptions, Acceptance, and ConcernsSeptember Beck0Tam T. Bui1Andrew Davies2Patrick Courtney3Alex Brown4Jef Geudens5Paul G. Royall6Department of Pharmacy, Faculty of Life Sciences & Medicine, Institute of Pharmaceutical Science, King’s College London, 150 Stamford Street, London SE1 9NH, UKBiomolecular Spectroscopy Centre, Optical and Chiroptical Spectroscopy Facility, Kings College London, London SE 11UL, UKHospital Pharmacy & Medicines Optimisation Team, NHS England London, Skipton House, 80 London Road, London SE1 6LH, UKTec-connection, Oberlohnstr 3, D78467 Konstanz, GermanySkyports, Unit LG.02, Edinburgh House, 170 Kennington Lane, London SE11 5DP, UKSkyports, Unit LG.02, Edinburgh House, 170 Kennington Lane, London SE11 5DP, UKDepartment of Pharmacy, Faculty of Life Sciences & Medicine, Institute of Pharmaceutical Science, King’s College London, 150 Stamford Street, London SE1 9NH, UKAnaphylaxis is a life-threatening condition where delays in medical treatment can be fatal. Such situations would benefit from the drone delivery of an adrenaline auto-injector such as EpiPen<sup>®</sup>. This study evaluates the potential risk, reward, and impact of drone transportation on the stability of adrenaline during episodes of anaphylaxis. Further, this study examines pharmacists’ perceptions on drone delivery—pharmacists approved the use of drones to deliver EpiPen<sup>®</sup> during emergencies but had concerns with drone safety and supply chain security. Laboratory simulated onboard drone conditions reflected typical missions. In these experiments, in vitro model and pharmaceutical equivalent formulations were subjected independently to 30 min vibrations at 5, 8.43, and 13.33 Hz, and temperature storage at 4, 25, 40, and 65 °C for 0, 0.5, 3, and 24 h. The chiral composition (an indicator of chemical purity that relates to molecular structure) and concentration of these adrenaline formulations were determined using ultraviolet (UV) and circular dichroism spectroscopy (CD). Adrenaline intrinsic stability was also explored by edge-of-failure experimentation to signpost the uppermost limits for safe transportation. During drone flight with EpiPen<sup>®</sup>, the temperature and vibration g-force were 10.7 °C and 1.8 g, respectively. No adverse impact on adrenaline was observed during drone flight and laboratory-simulated conditions shown by conformation to the British Pharmacopeia standards (<i>p</i> > 0.05 for CD and UV). This study showed that drone delivery of EpiPen<sup>®</sup> is feasible. There are more than 15,000 community pharmacies and ≈9000 GP surgeries spanning the UK, which are likely to provide achievable ranges and distances for the direct drone delivery of EpiPen<sup>®</sup>. The authors recommend that when designing future missions, in addition to medicine stability testing that models the stresses imposed by drone flight, one must conduct a perceptions survey on the relevant group of medical professionals, because their insights, acceptance, and concerns are extremely valuable for the design and evaluation of the mission.https://www.mdpi.com/2504-446X/4/4/66adrenalineEpiPen<sup>®</sup>stabilitychiralitydrone deliverypharmacist
spellingShingle September Beck
Tam T. Bui
Andrew Davies
Patrick Courtney
Alex Brown
Jef Geudens
Paul G. Royall
An Evaluation of the Drone Delivery of Adrenaline Auto-Injectors for Anaphylaxis: Pharmacists’ Perceptions, Acceptance, and Concerns
Drones
adrenaline
EpiPen<sup>®</sup>
stability
chirality
drone delivery
pharmacist
title An Evaluation of the Drone Delivery of Adrenaline Auto-Injectors for Anaphylaxis: Pharmacists’ Perceptions, Acceptance, and Concerns
title_full An Evaluation of the Drone Delivery of Adrenaline Auto-Injectors for Anaphylaxis: Pharmacists’ Perceptions, Acceptance, and Concerns
title_fullStr An Evaluation of the Drone Delivery of Adrenaline Auto-Injectors for Anaphylaxis: Pharmacists’ Perceptions, Acceptance, and Concerns
title_full_unstemmed An Evaluation of the Drone Delivery of Adrenaline Auto-Injectors for Anaphylaxis: Pharmacists’ Perceptions, Acceptance, and Concerns
title_short An Evaluation of the Drone Delivery of Adrenaline Auto-Injectors for Anaphylaxis: Pharmacists’ Perceptions, Acceptance, and Concerns
title_sort evaluation of the drone delivery of adrenaline auto injectors for anaphylaxis pharmacists perceptions acceptance and concerns
topic adrenaline
EpiPen<sup>®</sup>
stability
chirality
drone delivery
pharmacist
url https://www.mdpi.com/2504-446X/4/4/66
work_keys_str_mv AT septemberbeck anevaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT tamtbui anevaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT andrewdavies anevaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT patrickcourtney anevaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT alexbrown anevaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT jefgeudens anevaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT paulgroyall anevaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT septemberbeck evaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT tamtbui evaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT andrewdavies evaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT patrickcourtney evaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT alexbrown evaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT jefgeudens evaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns
AT paulgroyall evaluationofthedronedeliveryofadrenalineautoinjectorsforanaphylaxispharmacistsperceptionsacceptanceandconcerns